These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35095994)

  • 1. Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma.
    Fan X; Wen J; Bao L; Gao F; Li Y; He D
    Front Genet; 2021; 12():681809. PubMed ID: 35095994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis.
    Han X; Long W; Liu Y; Xu J
    Front Surg; 2022; 9():985034. PubMed ID: 36338652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Analyses of the Role of the Reader Protein of
    Shao XY; Dong J; Zhang H; Wu YS; Zheng L
    Front Mol Biosci; 2020; 7():577460. PubMed ID: 33344502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of
    Zheng R; Zhu HL; Hu BR; Ruan XJ; Cai HJ
    World J Clin Cases; 2020 Jul; 8(14):2917-2929. PubMed ID: 32775374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative Multi-Omics Analysis of Identified Ferroptosis-Marker RPL8 as a Candidate Oncogene Correlates with Poor Prognosis and Immune Infiltration in Liver Cancer.
    Fan S; Zhang S; Kong D; Wang H; Shi Y; Wang Z; Zheng H
    Comb Chem High Throughput Screen; 2023; 26(7):1298-1310. PubMed ID: 36017842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of the correlation of the pan-cancer gene HAUS5 with prognosis and immune infiltration in liver cancer.
    Zhang W; Yang C; Hu Y; Yi K; Xiao W; Xu X; Chen Z
    Sci Rep; 2023 Feb; 13(1):2409. PubMed ID: 36765148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of let-7c on the PI3K/Akt/FoxO signaling pathway in hepatocellular carcinoma.
    Li Y; Li P; Wang N
    Oncol Lett; 2021 Feb; 21(2):96. PubMed ID: 33376529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel five-gene signature predicts overall survival of patients with hepatocellular carcinoma.
    Wang Z; Pan L; Guo D; Luo X; Tang J; Yang W; Zhang Y; Luo A; Gu Y; Pan Y
    Cancer Med; 2021 Jun; 10(11):3808-3821. PubMed ID: 33934539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Pyroptosis-Related Prognostic Signature Combined With Experiments in Hepatocellular Carcinoma.
    Li H; Li T; Zhang X
    Front Mol Biosci; 2022; 9():822503. PubMed ID: 35309514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine triphosphate-binding cassette subfamily C members in liver hepatocellular carcinoma: Bioinformatics-driven prognostic value.
    Meng X; Dong S; Yangyang L; Wang S; Xu X; Liu T; Zhuang X
    Medicine (Baltimore); 2022 Feb; 101(7):e28869. PubMed ID: 35363194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prognostic Significance of
    Li Z; Cui Y; Duan Q; Zhang J; Shao D; Cao X; Gao Y; Wang S; Li J; Jones OD; Lei X; Wang L; Zhou X; Xu M; Ma J; Liu Y; Xu X
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic significance and carcinogenic mechanism of pan-cancer gene POU5F1 in liver hepatocellular carcinoma.
    He D; Zhang X; Tu J
    Cancer Med; 2020 Dec; 9(23):8782-8800. PubMed ID: 32978904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of subtypes of hepatocellular carcinoma and screening of prognostic molecular diagnostic markers based on cell adhesion molecule related genes.
    Sun R; Gao Y; Shen F
    Front Genet; 2022; 13():1042540. PubMed ID: 36482887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and immunological potential of PPM1G in hepatocellular carcinoma.
    Lin YR; Yang WJ; Yang GW
    Aging (Albany NY); 2021 May; 13(9):12929-12954. PubMed ID: 33952716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Bioinformatics and Experimental Analysis Identified TRIM28 a Potential Prognostic Biomarker and Correlated with Immune Infiltrates in Liver Hepatocellular Carcinoma.
    Han J; Wang Y; Zhou H; Ai S; Wan D
    Comput Math Methods Med; 2022; 2022():6267851. PubMed ID: 36238495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
    Wang R; Hu X; Liu X; Bai L; Gu J; Li Q
    PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDCA8 as an independent predictor for a poor prognosis in liver cancer.
    Shuai Y; Fan E; Zhong Q; Chen Q; Feng G; Gou X; Zhang G
    Cancer Cell Int; 2021 Mar; 21(1):159. PubMed ID: 33685433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation Mitochondrial Carrier 1 (MTCH1) Is Associated with Cell Proliferation, Invasion, and Migration of Liver Hepatocellular Carcinoma.
    Chen G; Mo S; Yuan D
    Biomed Res Int; 2021; 2021():9911784. PubMed ID: 34195286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
    Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H
    Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.